Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 7, 2013 - Issue
Submit an article Journal homepage
88
Views
55
CrossRef citations to date
0
Altmetric
Original Research

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma

Hongqing Zhuang1 Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;2 National Clinical Research Center of Cancer, Tianjin, People’s Republic of China;3 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China;4 Tianjin Lung Cancer Center, Tianjin, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Zhiyong Yuan1 Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;2 National Clinical Research Center of Cancer, Tianjin, People’s Republic of China;3 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China;4 Tianjin Lung Cancer Center, Tianjin, People’s Republic of China
,
Jun Wang1 Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;2 National Clinical Research Center of Cancer, Tianjin, People’s Republic of China;3 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China;4 Tianjin Lung Cancer Center, Tianjin, People’s Republic of China
,
Lujun Zhao1 Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;2 National Clinical Research Center of Cancer, Tianjin, People’s Republic of China;3 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China;4 Tianjin Lung Cancer Center, Tianjin, People’s Republic of China
,
Qingsong Pang1 Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;2 National Clinical Research Center of Cancer, Tianjin, People’s Republic of China;3 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China;4 Tianjin Lung Cancer Center, Tianjin, People’s Republic of China
&
Ping Wang1 Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People’s Republic of China;2 National Clinical Research Center of Cancer, Tianjin, People’s Republic of China;3 Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China;4 Tianjin Lung Cancer Center, Tianjin, People’s Republic of ChinaCorrespondence[email protected] [email protected]
Pages 1179-1186 | Published online: 08 Oct 2013

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.